TerrAscend (TSNDF) Free Cash Flow Growth (3y) (2024 - 2026)
TerrAscend (TSNDF) Free Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 39.19% |
| 10 | TerrAscend | 168.49 Mn | 168.02 Mn | 34.60 Mn | 8.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68% |
| Dec 31, 2025 | 46.97% |
| Sep 30, 2025 | 32.30% |
| Jun 30, 2025 | 54.05% |
| Mar 31, 2025 | 36.15% |
| Dec 31, 2024 | -48.82% |
| Sep 30, 2024 | 29.67% |
| Jun 30, 2024 | 44.17% |
| Mar 31, 2024 | 91.12% |